Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Differential Patterns of Cerebral Atrophy and Clinical Impacts in Cerebral Amyloid Angiopathy and Hypertensive Cerebral Small Vessel Disease

Author:Wu, Juanjuan   Sha, Yuhui   Ni, Jun   Peng, Bin   

Session Name:P9: Cerebrovascular Disease and Interventional Neurology: Translational Science, Advanced Diagnostics, and Prediction Modeling  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P9.005  

Author Institution:Peking Union Medical College Hospital, Beijing, China, People's Republic of  

Temporal and Regional Mortality Trends due to Stroke in Women with Breast Cancer in the United States from 1999 to 2020: A Retrospective Analysis

Author:Nadeem, Zain   Ahmad, Eeman   Akram, Umar   Fatima, Eeshal   Sardar, Muhammad Bilal   Nadeem, Aimen   Inam, Syed   Raashid, Sheharyar   

Session Name:P9: Cerebrovascular Disease and Interventional Neurology: Epidemiology and Community Stroke Care 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P9.006  

Author Institution:Allama Iqbal Medical College, Lahore, Pakistan  Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, Pakistan  Services Institute of Medical Sciences, Lahore, Pakistan  King Edward Medical University, Lahore, Pakistan  Marshall Neurology, Huntington, WV  

Capturing What Matters: Patient Reported LGI1-ANTibody Encephalitis Outcome RatiNg Scale (LANTERN)

Author:Kelly, Mark   Wagner, Barbara   Ceronie, Bryan   Strippel, Christine   Lin, Ann   Handel, Adam   Soltys, John   Binks, Sophie   Irani, Sarosh   Powell, Philip   

Session Name:P9: Autoimmune Neurology: Autoimmune Encephalitis 2  

Topic:Autoimmune Neurology  

Program Number:P9.006  

Author Institution:Royal College of Surgeons in Ireland, Dublin 2, Ireland  University of Oxford, Oxford, United Kingdom  Mayo Clinic, Jacksonville, FL  

Extension Study MT-1186-A04 Evaluating Oral Edaravone (Radicava ORS®) Continued Efficacy and Safety up to an Additional 48 Weeks in Patients With ALS

Author:Genge, Angela   Rothstein, Jeffrey   De Silva, Shari   Zinman, Lorne   Chum, Marvin   Chio, Adriano   Sobue, Gen   Doyu, Manabu   Selness, Daniel   Todorovic, Vesna   Sasson, Nissim   Takahashi, Fumihiro   Cecic, Michelle   Wamil, Art   Apple, Stephen   

Session Name:P9: General Neurology: Motor Neuron Disease 2  

Topic:General Neurology  

Program Number:P9.007  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD  Woodland Research Northwest, Rogers, AR  Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada  McMaster University Health Sciences Centre, Hamilton, ON, Canada  Università degli Studi di Torino, Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica (CRESLA), Torino, Italy  Nagoya University Graduate School of Medicine, Aichi Medical University, Nagoya, Japan  Department of Neurology, Aichi Medical University, Nagakute, Japan  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Mitsubishi Tanabe Pharma Europe, Ltd., London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel  

Subarachnoid Hemorrhage Secondary to Borrelia burgdorferi-Associated Vasculitis: A Case Report

Author:Khalighinejad, Farnaz   Lee, Samuel   Tamai, Janet   Wright, Paul   

Session Name:P9: Infectious Disease: Vector-borne Infections and the Nervous System 2  

Topic:Infectious Disease  

Program Number:P9.007  

Author Institution:Nuvance Health Medical Center, Poughkeepsie, NY  Nuvance Health Medical Center, Kingston, NY